Yellow fever: Tychan develops 1st antibody candidate treatment
by Press Release from Outbreak News Today on (#4V4QW)
Tychan's first-in-class monoclonal antibody candidate treatment for Yellow Fever (YF), called TY014, has successfully completed Phase 1A/1B safety trials in Singapore, it announced today. Tychan received regulatory approval from the Health Sciences Authority (HSA) of Singapore in November last year to conduct human trials for TY014, after a record setting timeline of 7 months from candidate to regulatory submission. ["]
The post Yellow fever: Tychan develops 1st antibody candidate treatment appeared first on Outbreak News Today.